Breast cancer treatment increases body fat [38], blood lipids [38], IGFBP-3 [39], negative impact on sexual functioning such as vulvo-vaginal atrophy [6,7], and decreases the activation of natural killer cells. Here, IGFBP3 is linked to breast carcinoma.